Skip to main content

Table 1 Mainly described some of the laboratory tests during the hospitalization of this patient

From: Suspected drug-induced liver injury associated with iguratimod: a case report and review of the literature

WBC(*10^9/L)

3.54

Albumin(g/L)

28.0

ANCA

negative

Neutrophils(%)

61.00

TBIL(umol/L)

263.62

ACL

negative

Lymphocytes(%)

29.70

DBIL(umol/L)

211.34

AMA-M

negative

Eosinophils(%)

0.60

IBIL(umol/L)

52.28

HBsAg

negative

Basophils(%)

0.80

AST(U/L)

747

HBsAb

positive

RBC(*10^12/L)

3.93

ALT(U/L)

986

HBeAb

positive

Hemoglobin(g/L)

119

ALP(U/L)

184

HbcAb

positive

Platelets(*10^9/L)

130

r-GTP(U/L)

256

HBV-DNA(IU/ml)

< 20

PT(S)

22.9

LDH(U/L)

346

anti-HA

negative

APTT(S)

60.2

TBA(umol/L)

205.85

anti-HCV

negative

PTA(%)

40.0

IgG4(ug/ml)

265

anti-HEV

negative

CRP(mg/L)

6.23

IgG(g/L)

13.68

anti-HSV

negative

PCT(ng/ml)

0.56

IgA(g/L)

2.41

anti-CMV IgM

negative

G test

negative

IgM(g/L)

2.62

anti-CMV IgG

positive

GM test

negative

complementC3(g/L)

0.26

anti-EBV VCA IgM

negative

Blood culture

negative

complement C4(g/L)

0.07

 

T-SPOT test

negative

ANA

positive,1:3200

RF

normal

anti-SS-A(60)

positive

Anti-O

negtive

anti-SS-A(52)

positive

 

anti-La/SS-B

positive